Stock Events

Stock Events

Microbot Medical 

$1.8900
157
+$0.03+1.61% 19:59 Today
-$0.02-1.06%21:31After hours

Statistics

Day High
1.88
Day Low
1.835
52W High
4.67
52W Low
1.6
Volume
14,184
Avg. Volume
-
Mkt Cap
126.94M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

18AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.2
-0.15
-0.1
-0.05
Expected EPS
-0.083333
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-22.89MNet Income

Analyst Ratings

7.00Average Price Target
The highest estimate is 12.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MBOT. It's not an investment recommendation.
NVIDIA
30
NVDA
Amazon
23
AMZN
Alphabet
22
GOOGL
Rocket Lab
21
RKLB

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap150.88B
Intuitive Surgical is a leading developer of robotic-assisted surgical systems, directly competing with Microbot Medical's robotic technologies aimed at improving clinical outcomes.
Medtronic
MDT
Mkt Cap106.49B
Medtronic offers robotic-assisted surgery solutions, competing in the same space as Microbot Medical with its innovative medical devices for minimally invasive procedures.
Smith & Nephew
SNN
Mkt Cap12.78B
Smith & Nephew provides advanced surgical robotics for orthopedic procedures, competing with Microbot Medical in the broader field of robotic-assisted surgeries.
Zimmer Biomet
ZBH
Mkt Cap18.01B
Zimmer Biomet Holdings, Inc. competes in the development of robotic solutions for orthopedic surgeries, a market that overlaps with Microbot Medical's target for their robotic devices.
Stryker
SYK
Mkt Cap125.18B
Stryker Corporation specializes in medical technologies, including robotic surgery systems, making it a competitor in the robotic-assisted surgical market alongside Microbot Medical.
Johnson & Johnson
JNJ
Mkt Cap633.19B
Johnson & Johnson, through its subsidiary Ethicon, is involved in the development of surgical robotics, competing with Microbot Medical's innovations in the same domain.
Boston Scientific
BSX
Mkt Cap67.09B
Boston Scientific Corporation offers products that compete in the minimally invasive medical device market, including endoscopy and interventional cardiology, areas where Microbot Medical also aims to innovate.
Abbvie
ABBV
Mkt Cap461.26B
AbbVie, while primarily known for its pharmaceuticals, has ventured into medical devices and robotics through acquisitions, indirectly competing with Microbot Medical's focus on robotic surgical solutions.
Alphabet
GOOGL
Mkt Cap4.39T
Alphabet Inc., through its Verily life sciences division, is exploring robotic surgery and other medical technologies, making it a potential future competitor in the innovative medical robotics space where Microbot Medical operates.

About

Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specifically targeting the field of minimally invasive procedures. Leveraging its proprietary micro-robotic technologies, which include ViRob, TipCAT, CardioSert, and Liberty, the company is actively developing several key products. These include a Self-Cleaning Shunt intended for the treatment of hydrocephalus and normal pressure hydrocephalus, as well as a single-use robotic system designed for various endovascular interventional applications. Additionally, Microbot Medical maintains a robust, multi-generational product pipeline. Its global intellectual property portfolio is substantial, encompassing 42 granted or allowed patents and an additional 23 patent applications currently under review. The company also benefits from a strategic collaboration agreement with Stryker Corporation, focusing on joint technology development. Established in 2010, Microbot Medical Inc. is headquartered in Hingham, Massachusetts.
Show more...
CEO
Mr. Harel Gadot
Employees
20
Country
United States
ISIN
US59503A2042

Listings

STU
DE
CY9D.STU
MU
DE
CY9D.MU
F
DE
CY9D.F
XNAS
US
MBOT

0 Comments

Share your thoughts

FAQ

What is Microbot Medical stock price today?▼
The current price of MBOT is $1.89 USD — it has increased by +1.61% in the past 24 hours. Watch Microbot Medical stock price performance more closely on the chart.
What is Microbot Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Microbot Medical stocks are traded under the ticker MBOT.
Is Microbot Medical stock price growing?▼
MBOT stock has fallen by -1.05% compared to the previous week, the month change is a +6.78% rise, over the last year Microbot Medical has showed a -28.41% decrease.
What is Microbot Medical market cap?▼
Today Microbot Medical has the market capitalization of 126.94M
When is the next Microbot Medical earnings date?▼
Microbot Medical is going to release the next earnings report on August 18, 2026.
What were Microbot Medical earnings last quarter?▼
MBOT earnings for the last quarter are -0.05 USD per share, whereas the estimation was -0.08 USD resulting in a +37.5% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Microbot Medical revenue for the last year?▼
Microbot Medical revenue for the last year amounts to 0 USD.
What is Microbot Medical net income for the last year?▼
MBOT net income for the last year is -22.89M USD.
How many employees does Microbot Medical have?▼
As of July 10, 2026, the company has 20 employees.
In which sector is Microbot Medical located?▼
Microbot Medical operates in the Health & Wellness sector.
When did Microbot Medical complete a stock split?▼
The last stock split for Microbot Medical was on September 05, 2018 with a ratio of 1:15.
Where is Microbot Medical headquartered?▼
Microbot Medical is headquartered in Hingham, United States.